Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.88 USD | -0.58% | +5.95% | -12.31% |
05-07 | Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates | MT |
05-07 | Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.31% | 1.9B | |
+28.54% | 48.16B | |
-1.09% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.14% | 25.59B | |
-22.80% | 18.96B | |
+8.26% | 12.92B | |
+28.76% | 12.03B | |
-1.89% | 11.77B |
- Stock Market
- Equities
- BEAM Stock
- News Beam Therapeutics Inc.
- Wedbush Adjusts Beam Therapeutics' Price Target to $57 From $48, Keeps Outperform Rating